$2.3 million in grants announced for SA SMEs in defence industry

Four Sovereign Industrial Capability Priority grants totalling $2.3 million, and all going to South Australian firms, were announced on Tuesday.   The SICP is a program offering between $50,000 and $1 million in dollar-matched funding to SMEs in defence. The successful firms in this round would use their funding to help investment in specialised tools…

Carnegie Mellon team tackles security issues for networked 3D printers

Carnegie Mellon University researchers have developed a tool for identifying and addressing cybersecurity vulnerabilities in networked 3D printers.   In work funded by the Pittsburgh university’s Manufacturing Futures Initiative, Vyas Sekar and Matthew McCormack have created a system to identify a printer’s security vulnerabilities and identify potential routes of attack.    “For example, it can…

Noxopharm reports anti-cancer effects of Veyonda

Sydney anti-cancer treatment company Noxopharm (ASX: NOX) has reported anti-cancer effects of its Veyonda treatment in a small group of patients suffering advanced prostate cancer. The 14 patients’ cancers were metastatic and they had exhausted all treatment options when given Veyonda in association with low-dosage radiation in a single lesion. After six months, cancer progression…

Lynas confident of continuing operations in Malaysia

Rare earths producer Lynas Corp is confident of a future operating in Malaysia following the extension of its licence to operate by six months. The company said in an operational update that the extension, announced in August, provided an operational pathway for continued operation. However the company has yet to receive further approvals following concerns…

LBT Innovations makes its first instrument sale in the EU

Medical technology and equipment developer LBT Innovations (ASX: LBT) has made its first European sale of its APAS Independence laboratory instrument (pictured). The sale was made to one of the largest clinical laboratories in the EU, Labor Dr Wisplinghoff, which employes more than 40 medical specialists. Laboratory director Professor Hilmar Wilplinghoff joined LBT Innovations CEO…